EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance

Guang Lei, Mingchuang Sun, Jun Cheng, Rui Ye, Zhengze Lu, Amber Horbath, David Huo, Shengrong Wu, Anagha Alapati, Sadhna Aggarwal, Zhihao Xu, Chao Mao und 14 weitere

Cancer Cell · 2025-06 · 43 (6) · 1076-1092.e5

DOI: 10.1016/j.ccell.2025.03.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025-06. Verfasst von Guang Lei und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Radiation Tolerance, Copper, Esophageal Neoplasms. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, University of Texas MD Anderson Cancer Center, University of Texas at Austin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis is a recently identified form of copper-dependent cell death. Here, we reveal that radiotherapy (RT) induces cuproptosis in cancer cells, independent of apoptosis and ferroptosis, and depletes lipoylated proteins and iron-sulfur (Fe-S) cluster proteins-both hallmarks of cuproptosis-in patient tumors. Mechanistically, RT elevates mitochondrial copper levels by upregulating copper transporter 1 (CTR1) and depleting mitochondrial glutathione, a copper chelator, thereby triggering cuproptosis. Integrated analyses of RNA sequencing (RNA-seq) from radioresistant esophageal cancer cells and single-cell RNA-seq from esophageal tumors of patients unresponsive to RT link radioresistance to the downregulation of BTB and CNC homology 1 (BACH1). This downregulation de-represses the expression of copper-sequestering metallothionein (MT) 1E/X, thereby mitigating cuproptosis and contributing to radioresistance. Copper ionophore treatment sensitizes radioresistant cancer cells and cell line- and patient-derived xenografts to RT by potentiating cuproptosis. Our findings unveil a link between RT and cuproptosis and inform a therapeutic strategy to overcome tumor radioresistance by targeting cuproptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation ToleranceCopperEsophageal NeoplasmsHumansAnimalsMiceCell Line, TumorMitochondriaCopper Transporter 1Xenograft Model Antitumor AssaysFerroptosisApoptosisMetallothioneinGene Expression Regulation, NeoplasticGlutathioneFemale

Stichwörter der Autor:innen

coppercuproptosismetallothioneinradioresistanceradiotherapy

Substanzen

CopperCopper Transporter 1MetallothioneinGlutathione

Autor:innen und Institutionen

  • Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Molecular and Cellular Oncology, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77…

Förderung

  • NCI NIH HHS
  • University of Texas MD Anderson Cancer Center
  • University of Texas at Austin
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health

Zitieren

APA

Lei, G., Sun, M., Cheng, J., Ye, R., Lu, Z., Horbath, A., Huo, D., Wu, S., Alapati, A., Aggarwal, S., Xu, Z., Mao, C., Yan, Y., Yao, J., Li, Q., Chen, X., Lee, H., Zhuang, L., Jiang, D., …, & Gan, B. (2025). Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. Cancer Cell, 43(6), 1076-1092.e5. https://doi.org/10.1016/j.ccell.2025.03.031

Vancouver

Lei G, Sun M, Cheng J, Ye R, Lu Z, Horbath A, et al. Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. Cancer Cell. 2025;43(6):1076-1092.e5. doi:10.1016/j.ccell.2025.03.031

BibTeX
@article{Lei2025,
  author = {Lei, Guang and Sun, Mingchuang and Cheng, Jun and Ye, Rui and Lu, Zhengze and Horbath, Amber and Huo, David and Wu, Shengrong and Alapati, Anagha and Aggarwal, Sadhna and Xu, Zhihao and Mao, Chao and Yan, Yuelong and Yao, Jun and Li, Qidong and Chen, Xiong and Lee, Hyemin and Zhuang, Li and Jiang, Dadi and Pataer, Apar and Roth, Jack A and Navin, Nicholas and Koong, Albert C and You, Mingjian James and Lin, Steven H and Gan, Boyi},
  title = {Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {6},
  pages = {1076--1092.e5},
  doi = {10.1016/j.ccell.2025.03.031}
}
Kostenlos starten →